Thomas Massie actually said...

"If companies couldn't recover their cost? That should be a fairly simple question to answer."

"This is according to the CBO, and they confirmed that there would be a loss of cures available on the market."

"Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused."

"We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases."